EAGLE PHARMACEUTICALS, INC. short interest in 2024

In 2024, EAGLE PHARMACEUTICALS, INC.'s disclosed short interest ran from 5.57% of shares outstanding on 12 Jan 2024 to 9.07% on 15 Apr 2024, a change of +3.50 percentage points. The year's high was 9.31% on 28 Mar 2024 and its low 5.57% on 12 Jan 2024, averaging 7.97% across 7 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 10.49 days on 28 Mar 2024. Full history: EAGLE PHARMACEUTICALS, INC..

Cite this page

Plain

Short position data for EAGLE PHARMACEUTICALS, INC. short interest in 2024: FINRA, compiled by howshorted.com, settlement date 15 Apr 2024. https://howshorted.com/us/company/egrx-2026/2024/

Wikipedia

<ref>{{cite web |title=EAGLE PHARMACEUTICALS, INC. short interest in 2024 short position data |url=https://howshorted.com/us/company/egrx-2026/2024/ |website=HowShorted |publisher=howshorted.com (data: FINRA) |date=2024-04-15 |access-date=2026-10-13}}</ref>

BibTeX

@misc{howshorted-eagle-pharmaceuticals-inc-short-interest-2024-04-15,
  title        = {EAGLE PHARMACEUTICALS, INC. short interest in 2024 short position data},
  author       = {{HowShorted}},
  howpublished = {\url{https://howshorted.com/us/company/egrx-2026/2024/}},
  note         = {Data: FINRA, settlement date 15 Apr 2024; accessed 2026-10-13},
  year         = {2024}
}

By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024

2024 in figures

Start of year: 5.57% (12 Jan 2024)
End of year: 9.07% (15 Apr 2024)
Change: +3.50 pp
High: 9.31% (28 Mar 2024)
Low: 5.57% (12 Jan 2024)
Average: 7.97%
Highest days to cover: 10.49 (28 Mar 2024)
SEC filings marked: 1

Every report in 2024

EAGLE PHARMACEUTICALS, INC. short interest in 2024
Settlement	Short interest	Days to cover
12 Jan 2024	5.57%	2.66
31 Jan 2024	6.13%	2.25
15 Feb 2024	8.19%	3.37
29 Feb 2024	8.57%	7.59
15 Mar 2024	8.95%	8.89
28 Mar 2024	9.31%	10.49
15 Apr 2024	9.07%	6.12

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.